NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections
Study May Proceed letter received from FDAPotential to initiate registrational study in 2024RADNOR, Pa., Dec. 18, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage...
United States Michael Manyak Prnewswire Nrx Pharmaceuticals Inc World Health Organization Alvogen Pharmaceuticals Nrx Pharmaceuticals
Source: marketscreener.com